Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model. Morishita A, Tadokoro T, Fujihara S, Iwama H, et al. PLoS One 2022;17:e0261310.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Morishita A, Tadokoro T, Fujihara S, Iwama H, et al. Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model. PLoS One 2022;17:e0261310.
PMID: 35192632